BusinessAdvancements in Medical Devices Contributing to the Growth of Left Ventricular Assist Device Market to Grow at a CAGR of 10.5% during 2018-2024 : Energias Market Research Pvt. Ltd.By Nasdaq OMXMar 19, 2018, 12:40 PM UTC
BusinessMesoblast Receives FDA Regenerative Medicine Advanced Therapy Designation for Its Cell Therapy in Heart Failure Patients With Left Ventricular Assist DevicesBy Nasdaq OMXDec 21, 2017, 11:00 AM UTC